Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vivo Capital IX, LLC Insider Profile
4 Followers
Vivo Capital IX, LLC, Ten Percent Owner at ALX Oncology Holdings, holds 6.17M shares in IO Biotech (Ticker: IOBT), holds 2.47M shares in Tarsus Pharmaceuticals (Ticker: TARS), holds 12.49M shares in Instil Bio (Ticker: TIL). Most recently, Vivo Capital IX, LLC Bought ― shares of IO Biotech on Aug 10, 2023 for an estimated value of 6.00M.
Vivo Capital IX, LLC ALX Oncology Holdings (ALXO)Ten Percent Owner
ALX Oncology Holdings (ALXO)
Ten Percent Owner
Ranked #22,046 out of 103,476 Corporate Insiders
Profitable Transactions
5 out of 9 Profitable Transactions
Average Return
+9.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vivo Capital IX, LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 21, 2020 - Jul 21, 2021
Return:+89.70%
The most profitable trade made by Vivo Capital IX, LLC
Vivo Capital IX, LLC's Trading History
ALX Oncology Holdings
Jul 21, 2020
Ten Percent Owner
Informative Buy
18.52M
$925.77K
Tarsus Pharmaceuticals
May 05, 2022
Ten Percent Owner
Informative Sell
65.83K
$42.61M
Instil Bio
Mar 25, 2021
Ten Percent Owner
Informative Buy
6.00M
$6.48M
IO Biotech
Aug 10, 2023
Ten Percent Owner
Informative Buy
6.00M
$11.11M
List of latest transactions for each holding click on a transaction to see Vivo Capital IX, LLC's performance on stock
You May Also Like
Vivo Capital IX, LLC insider profile FAQ
What is the percentage of profitable transactions made by Vivo Capital IX, LLC?
The percentage of profitable transactions made by Vivo Capital IX, LLC is 56%.
What is the average return per transaction made by Vivo Capital IX, LLC?
The average return per transaction made by Vivo Capital IX, LLC is 9.30%.
What stocks does Vivo Capital IX, LLC hold?
Vivo Capital IX, LLC holds: ALXO, TARS, TIL, IOBT stocks.
What was Vivo Capital IX, LLC’s latest transaction?
Vivo Capital IX, LLC latest transaction was an Informative Buy of $6.00M.
What was Vivo Capital IX, LLC's most profitable transaction?
Vivo Capital IX, LLC’s most profitable transaction was an Informative Buy of ALXO stock on July 21, 2020. The return on the trade was 89.70%.
What is Vivo Capital IX, LLC's role in ALX Oncology Holdings?
Vivo Capital IX, LLC's role in ALX Oncology Holdings is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.